Malta medical cannabis rules will allow clinical trials for products

Malta is set to pass legislation allowing for the production of medicinal cannabis, but in addition to allowing the manufacture of finished products, the legal changes lined up will also be allowing licensed companies to carry out research, including clinical trials.

After easing drug laws in 2015, the Government this year made it easier for patients to access medicinal cannabis, and has now moved to attract a growing medicinal cannabis industry to Malta – an industry estimated to be worth over $50 billion by 2025.

While Malta is not alone in making moves to attract medicinal cannabis companies, the legislative framework envisioned will put Malta at an advantage when compared to other jurisdictions, according to Antonio Costanzo, the head of international development at Nuuvera, a medicinal cannabis producer which recently acquired ASG Pharma, a local pharmaceutical company.

“Not all countries have done this, and we think that is a mistake because this is

... read more at: https://www.maltatoday.com.mt/news/national/85017/malta_medical_cannabis_rules_will_allow_clinical_trials_for_products